Blood Test to Measure DNA Damage in Blood
Terminated
- Conditions
- Prostate Cancer
- Registration Number
- NCT00523471
- Lead Sponsor
- AHS Cancer Control Alberta
- Brief Summary
To check the radiosensitivity level in individual patients based on their DNA damage level.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- Male
- Target Recruitment
- 40
Inclusion Criteria
- prostate cancer diagnosis
- undergoing radiotherapy
- agree to participate in study
Exclusion Criteria
- not willing to participate
- not undergoing radiotherapy
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Cross Cancer Institute
🇨🇦Edmonton, Alberta, Canada